IDEX (IEX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Annual Meeting scheduled for May 6, 2026, with voting open until May 5, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by April 22, 2026.
Virtual attendance and voting are available at the designated online platform.
Voting matters and shareholder proposals
Election of four Class I directors for three-year terms: Mark A. Beck, Carl R. Christenson, Katrina L. Helmkamp, and Alejandro Quiroz Centeno.
Advisory vote on approval of named executive officer compensation.
Ratification of Deloitte & Touche LLP as independent registered accounting firm for 2026.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Four director nominees are presented for election to serve three-year terms as Class I directors.
Latest events from IDEX
- Director elections, executive pay, auditor ratification, and ESG oversight are key 2026 meeting items.IEX
Proxy filing26 Mar 2026 - 8020-driven growth, high-margin innovation, and disciplined capital deployment fuel strong results.IEX
Investor presentation23 Mar 2026 - 8020 model and strategic acquisitions fuel growth in high-margin, specialized markets.IEX
Investor presentation5 Mar 2026 - Midpoint of phase three: HST drives growth, digital and AI adoption accelerate, M&A continues.IEX
Citi's Global Industrial Tech & Mobility Conference 202617 Feb 2026 - Record HST-driven growth and margin gains support 2026 outlook amid industrial headwinds.IEX
Q4 20254 Feb 2026 - $1B acquisition expands tech capabilities and market reach, with strong synergy and margin upside.IEX
M&A Announcement3 Feb 2026 - Q2 sales fell 5%, margins and EPS improved, guidance cut, and $1B Mott deal announced.IEX
Q2 20242 Feb 2026 - Q3 sales up 1%, adjusted EPS down 10%, Mott deal closed, and guidance steady amid macro risks.IEX
Q3 202417 Jan 2026 - Record Q4 sales and margin gains set up 2025 for organic growth and EPS expansion.IEX
Q4 20249 Jan 2026